Compugen

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Compugen and other ETFs, options, and stocks.

About CGEN

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases.

CEO

Anat Cohen-Dayag

CEOAnat Cohen-Dayag

Employees

Employees74

Headquarters

Holon, Tel Aviv

HeadquartersHolon, Tel Aviv

Founded

1993

Founded1993

Employees

Employees74

CGEN Key Statistics

Market cap

138.40M

Market cap138.40M

Price-Earnings ratio

-9.31

Price-Earnings ratio-9.31

Dividend yield

—

Dividend yield—

Average volume

178.18K

Average volume178.18K

High today

$1.50

High today$1.50

Low today

$1.46

Low today$1.46

Open price

$1.49

Open price$1.49

Volume

95.78K

Volume95.78K

52 Week high

$2.66

52 Week high$2.66

52 Week low

$1.13

52 Week low$1.13

Compugen

Why Robinhood?

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. Show more

CGEN Key Statistics

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases.